Details
| Original language | English |
|---|---|
| Title of host publication | Systems and Technologies for Clinical Diagnostics and Drug Discovery II |
| Pages | 228-239 |
| Number of pages | 12 |
| Volume | 3603 |
| Publication status | Published - 21 Apr 1999 |
| Event | BIOS '99 INTERNATIONAL BIOMEDICAL OPTICS SYMPOSIUM - San Jose, CA Duration: 23 Jan 1998 → 29 Jan 1998 |
Publication series
| Name | Proceedings of SPIE - The International Society for Optical Engineering |
|---|---|
| Publisher | SPIE |
| ISSN (Print) | 0277-786X |
Abstract
The new medical developments, e.g. immune therapy, patient orientated chemotherapy or even gene therapy, create a questionable doubt to the further requirement of animal tests. Instead the call for humanitarian reproductive in vitro models becomes increasingly louder. Pharmaceutical usage of in vitro has a long proven history. In cancer research and therapy, the effect of chemostatica in vitro in the so-called oncobiogram is being tested; but the assays do not always correlate with in vivo-like drug resistance and sensitivity. We developed a drug test system in vitro, feasible for therapeutic drug monitoring (TDM) by the combination of tissue cultivation in hollow fiber bioreactors (HFBR) and fiber optic sensors for monitoring the pharmaceutical effect. Using two fiber optic sensors - an optical oxygen sensor (MOPS) and a metabolism detecting Laserfluoroscope (LF), we were able to successfully monitor the biological status of tissue culture and the drug or toxic effects of in vitro pharmaceutical testing. Furthermore, we developed and patented a system for monitoring the effect of minor toxic compounds (VOC) which can induce Sick Building Syndrome (SBS).
ASJC Scopus subject areas
- Materials Science(all)
- Electronic, Optical and Magnetic Materials
- Physics and Astronomy(all)
- Condensed Matter Physics
- Computer Science(all)
- Computer Science Applications
- Mathematics(all)
- Applied Mathematics
- Engineering(all)
- Electrical and Electronic Engineering
Sustainable Development Goals
Cite this
- Standard
- Harvard
- Apa
- Vancouver
- BibTeX
- RIS
Systems and Technologies for Clinical Diagnostics and Drug Discovery II. Vol. 3603 1999. p. 228-239 (Proceedings of SPIE - The International Society for Optical Engineering).
Research output: Chapter in book/report/conference proceeding › Conference contribution › Research › peer review
}
TY - GEN
T1 - Applying Fiber Optical Methods for Toxicological Testing in Vitro
AU - Maerz, Holger K.
AU - Buchholz, Rainer
AU - Emmrich, Frank
AU - Finks, Frank
AU - Geddes, Clive L.
AU - Pfeifer, Lutz
AU - Raabe, Ferdinand
AU - Scheper, Thomas
AU - Ulrich, Elizabeth
AU - Marx, Uwe
PY - 1999/4/21
Y1 - 1999/4/21
N2 - The new medical developments, e.g. immune therapy, patient orientated chemotherapy or even gene therapy, create a questionable doubt to the further requirement of animal tests. Instead the call for humanitarian reproductive in vitro models becomes increasingly louder. Pharmaceutical usage of in vitro has a long proven history. In cancer research and therapy, the effect of chemostatica in vitro in the so-called oncobiogram is being tested; but the assays do not always correlate with in vivo-like drug resistance and sensitivity. We developed a drug test system in vitro, feasible for therapeutic drug monitoring (TDM) by the combination of tissue cultivation in hollow fiber bioreactors (HFBR) and fiber optic sensors for monitoring the pharmaceutical effect. Using two fiber optic sensors - an optical oxygen sensor (MOPS) and a metabolism detecting Laserfluoroscope (LF), we were able to successfully monitor the biological status of tissue culture and the drug or toxic effects of in vitro pharmaceutical testing. Furthermore, we developed and patented a system for monitoring the effect of minor toxic compounds (VOC) which can induce Sick Building Syndrome (SBS).
AB - The new medical developments, e.g. immune therapy, patient orientated chemotherapy or even gene therapy, create a questionable doubt to the further requirement of animal tests. Instead the call for humanitarian reproductive in vitro models becomes increasingly louder. Pharmaceutical usage of in vitro has a long proven history. In cancer research and therapy, the effect of chemostatica in vitro in the so-called oncobiogram is being tested; but the assays do not always correlate with in vivo-like drug resistance and sensitivity. We developed a drug test system in vitro, feasible for therapeutic drug monitoring (TDM) by the combination of tissue cultivation in hollow fiber bioreactors (HFBR) and fiber optic sensors for monitoring the pharmaceutical effect. Using two fiber optic sensors - an optical oxygen sensor (MOPS) and a metabolism detecting Laserfluoroscope (LF), we were able to successfully monitor the biological status of tissue culture and the drug or toxic effects of in vitro pharmaceutical testing. Furthermore, we developed and patented a system for monitoring the effect of minor toxic compounds (VOC) which can induce Sick Building Syndrome (SBS).
UR - http://www.scopus.com/inward/record.url?scp=0032640437&partnerID=8YFLogxK
U2 - 10.1117/12.346746
DO - 10.1117/12.346746
M3 - Conference contribution
AN - SCOPUS:0032640437
VL - 3603
T3 - Proceedings of SPIE - The International Society for Optical Engineering
SP - 228
EP - 239
BT - Systems and Technologies for Clinical Diagnostics and Drug Discovery II
T2 - BIOS '99 INTERNATIONAL BIOMEDICAL OPTICS SYMPOSIUM
Y2 - 23 January 1998 through 29 January 1998
ER -